Literature DB >> 11028106

Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease.

M M Oliveira1, M Einicker-Lamas.   

Abstract

Chagas' disease is a debilitating and often fatal disease caused by the protozoan parasite Trypanosoma cruzi. The great majority of surface molecules in trypanosomes are either inositol-containing phospholipids or glycoproteins that are anchored into the plasma membrane by glycosylphosphatidylinositol anchors. The polyalcohol myo-inositol is the precursor for the biosynthesis of these molecules. In this brief review, recent findings on some aspects of the molecular and cellular fate of inositol in T. cruzi life cycle are discussed and identified some points that could be targets for the development of parasite-specific therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028106     DOI: 10.1590/s0001-37652000000300015

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  3 in total

1.  Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues.

Authors:  Rodrigo P Soares; Ana C Torrecilhas; Rafael R Assis; Marcele N Rocha; Felipe A Moura e Castro; Gustavo F Freitas; Silvane M Murta; Sara L Santos; Alexandre F Marques; Igor C Almeida; Alvaro J Romanha
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

2.  Two major inositol transporters and their role in cryptococcal virulence.

Authors:  Yina Wang; Tong-bao Liu; Guillaume Delmas; Steven Park; David Perlin; Chaoyang Xue
Journal:  Eukaryot Cell       Date:  2011-03-11

3.  Biochemical and phylogenetic analyses of phosphatidylinositol production in Angomonas deanei, an endosymbiont-harboring trypanosomatid.

Authors:  Allan C de Azevedo-Martins; João M P Alves; Fernando Garcia de Mello; Ana Tereza R Vasconcelos; Wanderley de Souza; Marcelo Einicker-Lamas; Maria Cristina M Motta
Journal:  Parasit Vectors       Date:  2015-04-24       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.